| Literature DB >> 33658993 |
Wiebke Nadolni1, Roland Immler2, Kilian Hoelting1, Marco Fraticelli1, Myriam Ripphahn2, Simone Rothmiller3, Masayuki Matsushita4, Ingrid Boekhoff1, Thomas Gudermann1, Markus Sperandio2, Susanna Zierler1,5.
Abstract
During inflammation, neutrophils are one of the first responding cells of innate immunity, contributing to a fast clearance of infection and return to homeostasis. However, excessive neutrophil infiltration accelerates unsolicited disproportionate inflammation for instance in autoimmune diseases such as rheumatoid arthritis. The transient-receptor-potential channel-kinase TRPM7 is an essential regulator of immune system homeostasis. Naïve murine T cells with genetic inactivation of the TRPM7 enzyme, due to a point mutation at the active site, are unable to differentiate into pro-inflammatory T cells, whereas regulatory T cells develop normally. Moreover, TRPM7 is vital for lipopolysaccharides (LPS)-induced activation of murine macrophages. Within this study, we show that the channel-kinase TRPM7 is functionally expressed in neutrophils and has an important impact on neutrophil recruitment during inflammation. We find that human neutrophils cannot transmigrate along a CXCL8 chemokine gradient or produce reactive oxygen species in response to gram-negative bacterial lipopolysaccharide LPS, if TRPM7 channel or kinase activity are blocked. Using a recently identified TRPM7 kinase inhibitor, TG100-115, as well as murine neutrophils with genetic ablation of the kinase activity, we confirm the importance of both TRPM7 channel and kinase function in murine neutrophil transmigration and unravel that TRPM7 kinase affects Akt1/mTOR signaling thereby regulating neutrophil transmigration and effector function. Hence, TRPM7 represents an interesting potential target to treat unwanted excessive neutrophil invasion.Entities:
Keywords: TRPM7; chemotaxis; inflammation; innate immunity; ion channel; kinase; migration; neutrophils (PMNs)
Mesh:
Substances:
Year: 2021 PMID: 33658993 PMCID: PMC7917126 DOI: 10.3389/fimmu.2020.606893
Source DB: PubMed Journal: Front Immunol ISSN: 1664-3224 Impact factor: 7.561